Sir,

One of the troublesome side-effects of tricyclic anti-depressants is urinary hesitancy due to their anticholinergic effects.[@CIT1]

Reboxetine, the only selective noradrenaline reuptake inhibitor, is an effective and well-tolerated antidepressant. Since it has low affinity for muscarinic, cholinergic receptors,[@CIT2] anticholinergic side-effects such as urinary retention or hesitancy are not expected.

However, some patients on reboxetine (2--4 mg/day) complain of urinary hesitancy. A peripheral noradrenergic mechanism termed 'pseudoanticholinergic syndrome' may be responsible for this side-effect.[@CIT3]

Tamsulosin, an alpha-1A receptor antagonist, is recommended for reboxetine-induced urinary hesitancy.[@CIT4][@CIT5] Therefore, the following precautions should be taken while a patient is on reboxetine:

Enquire about any history of urinary complaints beforehand.In elderly patients, titrate the dose upwards gradually.During follow-up visits, ask patients whether they have any urinary hesitancy.If reboxetine-induced urinary hesitancy does set in, then rather than withdrawing reboxetine, a trial of capsule tamsulosin (available locally as Urinat) can be started in a single dose of 0.4 mg half-an-hour after dinner every day.
